https://www.live-feeds.com/feed/novo-nordisk-rebrands-as-novo-announces-cultural-resetContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/novo-nordisk-rebrands-as-novo-announces-cultural-resethttps://www.live-feeds.com/feed/novo-nordisk-rebrands-as-novo-announces-cultural-reset#u69435Tue, 15 Sep 2026 21:23:42 +0000Novo Nordisk has rebranded to Novo to increase brand recognition and competitiveness in the obesity market. The drugmaker is implementing a new culture framework and corporate changes to shift toward a more customer-focused approach. This identity shift accompanies an effort to broaden operations to regain market share in diabetes and obesity treatments. The company produces the weight-loss drugs Wegovy and Ozempic and is currently facing intense competition in the anti-obesity sector.Why it mattersThe rebranding occurs as Novo shares have fallen 15% in 2026. This decline persists despite the